Howard Berman

Recent appearances

• 

  A New Hope for Newborn Brain Injury - Dr. Howard Berman - CEO, ReAlta Life Sciences

  May 07, 2026 · 📺 Progress, Potential, and Possibilities

  Every year, thousands of newborns suffer devastating brain injury during birth - and despite decades of research, there are still no approved drug therapies for Hypoxic Ischemic Encephalopathy (HIE). But one biotech company believes it may finally have a solution. Dr. Howard Berman, Ph.D. is Chief Executive Officer and Chairman of ReAlta Life Sciences ( https://realtalifesciences.com/ ), a clinical-stage biotechnology company developing novel therapies for severe inflammatory diseases. Dr. Berman brings a unique background spanning neuroscience, pharmacology, medical affairs, technology tran…

  Watch on YouTube ↗

• 

  Dr. Howard Berman - Founder and CEO at Coya Therapeutics, Inc.

  September 04, 2025 · 📺 The Courageous Podcast

  What if you could slow down Alzheimer’s or ALS? That’s exactly the deeply personal journey Dr. Howard Berman, Founder and CEO at Coya Therapeutics, finds himself on. To day, Howard runs a mission-driven company that is making remarkable breakthroughs in the world of T-Cells. Driven by his father's personal battle with Dementia, Howard has embarked on a relentless quest for a cure. Along his journey, he uncovered an extraordinary technology devised by the brilliant Dr. Stanley Appel that gave him the courage to leave his last life in pharmaceuticals. In this episode, Dr. Berman speaks on the sc…

  Watch on YouTube ↗

• 

  Coya Therapeutics (COYA) CEO on $5M Alzheimer’s Drug Discovery Foundation Investment

  May 23, 2024 · 📺 Schwab Network

  Coya Therapeutics (COYA) is a clinical-stage company focused on developing multi-modality Treg therapies. CEO Howard Berman joins Nicole Petallides to give an overview of the company. He talks about how COYA’s leading candidate is Coya 302 and how the Alzheimer’s Drug Discovery Foundation invested $5M in COYA. Tune in to find out more about the stock market today. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-.…

  Watch on YouTube ↗

• 

  Without Adversity There’s No Success. Dr. Howard Berman CEO and Chairman of Coya Therapeutics $COYA

  May 06, 2024 · 📺 Smart Money Circle Show Hosted By Adam Sarhan

  Guest: Dr. Howard Berman CEO and Chairman of Coya Therapeutics $COYA Ticker: $COYA Website: https://coyatherapeutics.com/ Bio: Chief Executive Officer and Chairman of the Board Howard co-founded Nicoya Health in 2020 to realize the vision and research of Dr. Stanley Appel and merged the company with Coya Therapeutics in 2021 where he currently serves as Chairman and CEO. He has over 18 years of entrepreneurial and industry experience working at the interplay of science and business. His experience offers him a unique combination of business acumen and scientific credibility with the abi…

  Watch on YouTube ↗

• 

  Treg Cell Therapy for Neurodegenerative Diseases ft. Dr. Howard Berman

  April 17, 2024 · 📺 Xtalks

  In this episode, Ayesha spoke with Howard Berman, PhD, Founder and CEO of Coya Therapeutics, a clinical-stage biotech company developing regulatory T cell (Treg) therapies targeting neurodegenerative, autoimmune and metabolic diseases. Dr. Berman founded Coya Therapeutics in 2021. Dr. Berman has over 18 years of entrepreneurial and industry experience working at the interplay of science and business. His experience offers him a unique combination of business acumen and scientific credibility with the ability to assess, quantify and bridge both disciplines. Dr. Berman gained corporate experi…

  Watch on YouTube ↗

• 

  Chardan Leadership Call: Coya Therapeutics (COYA)

  January 31, 2024 · 📺 Chardan

  Featuring Howard Berman, CEO; Fred Grossman, DO, FAPA, President & CMO; Arun Swaminathan, PhD, Chief Business Development Officer

  Watch on YouTube ↗

• 

  Dr. Howard Berman Founder/CEO of Coya Therapeutics talks about the power of T-regs.

  October 05, 2023 · 📺 BizTV

  Dr. Howard Berman, Founder/CEO of Coya Therapeutics, talks with Sully and Mike Costa about the power of T-regs and their medication that has the potential to slow down or stop autoimmune and metabolic diseases. #bigbizshow #biztv #drhowardberman #coyatherapeutics #coya #tregs #autoimmunedisease #als #metabolicdisease #sully #mikecosta BizTV features compelling, fast-paced content that engages the audience in marketing, technology, and business innovations. A hip, fresh look at the game of business, BizTV empowers viewers to dive into entrepreneurship, the markets, investing, and travel.…

  Watch on YouTube ↗

• 

  Nasdaq Interview with Howard Berman, CEO of Coya Therapeutics

  October 05, 2023 · 📺 Quantum

  Howard Berman, CEO of Coya Therapeutics, a biotechnology company, had an interview with Jane King from Nasdaq on September 27, 2023. Howard shared the announcement about the acquisition of exclusive, global rights for a proprietary Exosome Engineering Technology from Carnegie Mellon University. This technology holds promise for diverse applications spanning neurodegeneration, autoimmune conditions, and oncology. Coya Therapeutics (NASDAQ: COYA) is a clinical-stage company focused on developing multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. Website ht…

  Watch on YouTube ↗

• 

  Coya Therapeutics (NASDAQ: COYA) promising ALS treatment

  July 11, 2023 · 📺 LilaMax Media

  Jane King interviews Howard Berman, Ph.D., CEO & Chairman of the Board, Coya Therapeutics (NASDAQ: COYA). https://coyatherapeutics.com Innovators with Jane King profiles tech companies and thought leaders in the space. We're showing you a glimpse of the future. Headquartered in Houston, TX, Coya Therapeutics, Inc. (Nasdaq: COYA) is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target systemic inflammation and neuroinflammation. Dysfunctional Tregs underlie numerous con…

  Watch on YouTube ↗

• 

  KIAH Houston: Coya Shares the Story Behind Coya Therapeutics and Its Research on Alzheimer's

  June 19, 2023 · 📺 Quantum

  Howard Berman, CEO of Houston-based Coya Therapeutics, appeared on KIAH's CW39 Houston show on June 9, 2023. In the interview, he tells his personal story which led to him founding Coya and developing treatments for dementia, ALS and Alzheimer's disease. Howard also shared how inflammation is a driver of neurodegenerative diseases and that Coya is at the forefront of showing how ramping up Tregs can slow or even stop disease progression based on their trials with Alzheimer's and ALS patients. -----------------------------------------------------------------------------------------------------…

  Watch on YouTube ↗

• 

  Revolutionizing Therapy for ALS & Alzheimers with Coya Therapeutics' Howard Berman & Daniel Barvin

  June 08, 2023 · 📺 Forging the Future with Chris Howard

  Chris interviews the leaders of Coya Therapeutics, a pharmaceutical company based in Houston that is revolutionizing the push for effective neurodegenerative disease therapies. Coya went public with only five team members after working with world-renowned researcher and neurologist Stanley Appel to commercialize new therapies for neurological diseases in order to make them publically available. Join Chris Howard on this episode as he interviews Dr. Howard Berman, the Founder and CEO of Coya, and Daniel Barvin, the Vice President of Operations and Patient Advocacy, where they share the backgrou…

  Watch on YouTube ↗

• 

  Coya CEO Howard Berman, Ph.D. - Appearance on Bloom TV

  June 01, 2023 · 📺 Coya Therapeutics

  Coya CEO, Howard Berman, Ph.D., joined Gayle Guyardo on Bloom to discuss the role of #inflammation in #neurodegenerative diseases and share results from Coya's proof-of-concept open-label studies in both #ALS and #AlzheimersDisease.

  Watch on YouTube ↗